BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27227955)

  • 1. Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China.
    Zang J; Li C; Zhao LN; Wang JH; Xu M; Luo SQ; Hitchcock YJ; Shi M
    Medicine (Baltimore); 2016 May; 95(21):e3794. PubMed ID: 27227955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
    Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
    BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
    Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
    Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
    Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Feng M; Wang W; Fan Z; Fu B; Li J; Zhang S; Lang J
    Radiat Oncol; 2013 Sep; 8():208. PubMed ID: 24007375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
    Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.
    Jiang F; Jin T; Feng XL; Jin QF; Chen XZ
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C179-84. PubMed ID: 26506872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
    Zong J; Lin S; Lin J; Tang L; Chen B; Zhang M; Zhang Y; Xu L; Chen Y; Xiao Y; Fang Y; Pan J
    Oral Oncol; 2015 Mar; 51(3):254-9. PubMed ID: 25467207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
    Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
    BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
    Liu K; Han Y; Ma B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
    Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
    Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.
    Zeng L; Tian YM; Sun XM; Huang Y; Chen CY; Han F; Liu S; Lan M; Guan Y; Deng XW; Lu TX
    Strahlenther Onkol; 2014 Oct; 190(11):993-1000. PubMed ID: 24838409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
    Zhang LL; Zhou GQ; Li YY; Tang LL; Mao YP; Lin AH; Ma J; Qi ZY; Sun Y
    Cancer Med; 2017 Dec; 6(12):2822-2831. PubMed ID: 29034992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of 358 Cases of Locally Advanced Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiation Therapy: Improving the Seventh Edition of the American Joint Committee on Cancer T-Staging System.
    Zhou Q; He Y; Zhao Y; Wang Y; Kuang W; Shen L
    Biomed Res Int; 2017; 2017():1419676. PubMed ID: 28265567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
    Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
    Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
    Guo R; Sun Y; Yu XL; Yin WJ; Li WF; Chen YY; Mao YP; Liu LZ; Li L; Lin AH; Ma J
    Radiother Oncol; 2012 Sep; 104(3):294-9. PubMed ID: 22998947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
    BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Mao YP; Tang LL; Chen L; Sun Y; Qi ZY; Zhou GQ; Liu LZ; Li L; Lin AH; Ma J
    Chin J Cancer; 2016 Dec; 35(1):103. PubMed ID: 28031050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.